Charles R. Goulding and Justin Snyder review findings from a webinar describing unique AM applications for healthcare.
Charles R. Goulding and Preeti Sulibhavi examine Stratasys’ capabilities to match injection molding technology.
Charles R. Goulding and Preeti Sulibhavi review a fascinating recent webinar exploring how recent US legislation affects additive manufacturing.
Charles R. Goulding and Preeti Sulibhavi review a webinar focusing on use of additive manufacturing in space applications.
Charles R. Goulding and Preeti Sulibhavi review a webinar from the Additive Manufacturing Coalition.
Charles R. Goulding considers financing options in the 3D printing industry.
Jigs and fixtures are a staple application in 3D printing, but there’s much to know when using them.
One of the biggest positives of 3D printing is that no tooling is required — but it might just be perfect for making parts including jigs, fixtures, end-use parts, and even tooling.
With the cancellation of countless in-person 3D print events, companies have leveraged technology to keep in contact with clients and prospects in unique ways.
Charles R. Goulding and Adam Friedman review a recent webinar discussing the 3D printing of electronics.
With so many virtual events popping up, we all need to consider strategies when it comes to tuning in.
We’ve been discussing a lot about virtual 3D printing events lately, as current global circumstance is keeping us physically separated.
Fabbaloo’s Rapid-Fire Interview Day is coming up this Thursday, 23 April!
Fabbaloo will be hosting a day of virtual interviews to touch base directly with 3D printing companies and catch up on their latest.
Yes, we’ll primarily remember 2020 as the Year of Pandemic, but it’s quickly taking on another face: the Year of the 3D Printing Webinar.
A conversation in industrial 3D printing proved revealing as to the place of this advanced manufacturing technology in crisis and beyond.
Fabbaloo and Rize partnered on a webinar discussing Trends in 3D Printing for Production; Addressing Challenges with Rize.